NEW YORK (GenomeWeb) – PerkinElmer said after the stock market closed on Thursday that its second quarter revenues grew 3 percent year over year.

The Waltham, Mass.-based company said that for the three months ended June 29, revenues were up to $556.2 million from $540.7 million in the year-ago quarter and fell short of the consensus Wall Street estimate of $571.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.